Compile Data Set for Download or QSAR
maximum 50k data
Found 356 Enz. Inhib. hit(s) with all data for entry = 6696
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135414(US8846657, 14.4)
Affinity DataIC50: <1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135419(US8846657, 15.3 | US8846657, 15.4)
Affinity DataIC50: <1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135425(US8846657, 16.1)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135435(US8846657, 18.3)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135436(US8846657, 18.4)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135438(US8846657, 18.6)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135439(US8846657, 18.7)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135445(US8846657, 18.13)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135257(US8846657, 3.150)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135263(US8846657, 3.156 | US8846657, 3.157 | US8846657, 3...)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135274(US8846657, 3.167 | US8846657, 3.168)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135286(US8846657, 4.3 | US8846657, 4.4)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135106(US8846657, 2.1)
Affinity DataIC50: <1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135107(US8846657, 2.2)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135111(US8846657, 3.1)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135112(US8846657, 3.2)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135113(US8846657, 3.3)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135117(US8846657, 3.7)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135115(US8846657, 3.10 | US8846657, 3.11 | US8846657, 3.5)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135131(US8846657, 3.22)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135134(US8846657, 3.26 | US8846657, 3.27 | US8846657, 3.2...)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135144(US8846657, 3.36)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135147(US8846657, 3.39)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135148(US8846657, 3.40 | US8846657, 3.43 | US8846657, 3.4...)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135148(US8846657, 3.40 | US8846657, 3.43 | US8846657, 3.4...)
Affinity DataIC50: <1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135154(US8846657, 3.46)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135158(US8846657, 3.50 | US8846657, 3.53 | US8846657, 3.5...)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135158(US8846657, 3.50 | US8846657, 3.53 | US8846657, 3.5...)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135165(US8846657, 3.57 | US8846657, 3.59 | US8846657, 3.6...)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135178(US8846657, 3.70)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135179(US8846657, 3.72 | US8846657, 3.75 | US8846657, 3.7...)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135185(US8846657, 3.78)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM148141(US8962611, 3.81)
Affinity DataIC50: <1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135209(US8846657, 3.102 | US8846657, 3.103)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135197(US8846657, 3.90)
Affinity DataIC50: <1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM148142(US8962611, 3.91)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135199(US8846657, 3.92)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135201(US8846657, 3.94)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135205(US8846657, 3.98)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135208(US8846657, 3.101)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135209(US8846657, 3.102 | US8846657, 3.103)
Affinity DataIC50: <1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135213(US8846657, 3.106)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135239(US8846657, 3.132)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135241(US8846657, 3.134 | US8846657, 3.135 | US8846657, 3...)
Affinity DataIC50: <1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135248(US8846657, 3.141)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135249(US8846657, 3.142)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135251(US8846657, 3.144)
Affinity DataIC50: <1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135252(US8846657, 3.145)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135253(US8846657, 3.146)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM135254(US8846657, 3.147)
Affinity DataIC50:  1nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 356 total ) | Next | Last >>
Jump to: